The terms BP, EP and USP indicate the pharmacopoeial standards against which the material is tested:
BP refers to the British Pharmacopoeia.
EP or Ph. Eur. refers to the European Pharmacopoeia.
USP or USP-NF refers to the United States Pharmacopeia–National Formulary.
These standards help pharmaceutical manufacturers evaluate whether a batch of maltodextrin meets applicable identity, purity and quality requirements.
Maltodextrin is produced through the controlled partial hydrolysis of starch using suitable acids, enzymes or a combination of both. Common starch sources include corn, potato, rice, wheat and tapioca.
USP-NF defines maltodextrin as a non-sweet, nutritive mixture of saccharide polymers composed of D-glucose units, with a dextrose equivalent below 20. It may also be physically modified to improve its processing or functional characteristics.
Commercial maltodextrin is normally supplied as a white or nearly white amorphous powder. It is generally neutral or only slightly sweet in taste and is readily dispersible or soluble in water. Its exact flowability, bulk density, viscosity and hygroscopicity depend on the starch source, manufacturing process and dextrose equivalent.
Pharma grade means that the material is manufactured, tested and documented for use in pharmaceutical or healthcare formulations.
However, the phrase “pharmaceutical grade” should not be evaluated only as a marketing description. Buyers should confirm the specific pharmacopoeial standard, current monograph version, manufacturing controls and batch documentation.
A pharmaceutical-grade maltodextrin should normally be supported by documentation such as:
Batch-specific Certificate of Analysis
Product specification sheet
Safety Data Sheet
Manufacturing origin information
Applicable BP, EP or USP-NF compliance statement
Allergen and GMO statements when required
Microbiological test data
Residual solvent or elemental impurity information when applicable
The required documents may vary according to the destination market, dosage form and regulatory submission.
Maltodextrin USP grade refers to material tested against the applicable USP-NF monograph.
The United States Pharmacopeia publishes public quality standards for medicines, pharmaceutical ingredients and excipients. For maltodextrin, the monograph provides the official definition and relevant analytical requirements that must be considered when USP-NF compliance is claimed.
Typical quality-control categories may include:
Description and identification
Dextrose equivalent
Acidity or alkalinity
pH
Loss on drying or moisture
Sulfated ash or residue on ignition
Impurity control
Microbiological quality
Packaging and storage requirements
Exact tests and acceptance criteria should always be checked against the current official USP-NF edition rather than an outdated specification.
Companies purchasing material for the US market can view our Maltodextrin USP product page for sourcing and inquiry information.
Maltodextrin EP grade, more accurately described as Maltodextrin Ph. Eur. grade, is tested according to the European Pharmacopoeia requirements.
The European Pharmacopoeia establishes legally recognized quality standards for pharmaceutical substances and excipients used across its participating countries. A Ph. Eur.-grade material should comply with the applicable monograph and relevant general chapters in force when the batch is manufactured or released.
European pharmaceutical buyers may also request supporting information related to:
Source of starch
Manufacturing process
Microbial limits
Elemental impurities
GMO status
Allergen status
BSE/TSE risk
Country of origin
Stability or retest period
Packaging suitability
Compliance with a monograph does not eliminate the pharmaceutical manufacturer’s responsibility to qualify the supplier and confirm that the excipient is suitable for the intended formulation.
Maltodextrin BP grade is intended to comply with the applicable requirements of the British Pharmacopoeia.
The BP is the official collection of quality standards for pharmaceutical substances and medicinal products in the United Kingdom. It includes European Pharmacopoeia texts as well as additional national BP standards. The official BP guidance states that ingredients used in pharmaceutical products should comply with the relevant BP or Ph. Eur. monograph where one is published.
Because pharmacopoeial standards are periodically revised, buyers should state the required edition when sending an inquiry. For example, simply requesting “BP grade” without identifying the current standard or required test documentation may lead to specification differences during supplier qualification.
BP, EP and USP maltodextrin products may be chemically similar, but the compliance claims are not automatically interchangeable.
Different pharmacopoeias may use different:
Analytical procedures
Reagents and reference standards
Impurity limits
Calculation methods
Microbiological requirements
Packaging descriptions
Reporting formats
Some pharmaceutical excipient monographs are harmonized internationally through the Pharmacopoeial Discussion Group, while others retain local requirements. EDQM’s harmonization information specifically distinguishes harmonized sections from local pharmacopoeial requirements.
Therefore, a buyer should not assume that a USP-compliant batch automatically meets EP or BP requirements. Dual- or multi-compendial compliance should be supported by a specification and Certificate of Analysis covering all requested standards.
Maltodextrin can perform several functions depending on the formulation and grade selected.
Maltodextrin can increase the volume of low-dose formulations, powders, granules and sachets. It helps create a practical batch size while supporting more uniform distribution of other ingredients.
In wet or dry granulation systems, suitable maltodextrin grades may improve particle adhesion and granule formation. The actual concentration should be determined through formulation trials because excessive binder can affect tablet disintegration or dissolution.
Maltodextrin is frequently used as a carrier for flavors, vitamins, botanical extracts and other formulation ingredients. It can support the conversion of liquid or semi-liquid ingredients into free-flowing powders through processes such as spray drying.
Its film-forming and matrix-forming characteristics make maltodextrin useful in encapsulation systems. Research has also examined maltodextrin as a platform material for pharmaceutical oral films and other drug-delivery applications.
Maltodextrin may be used in oral powders, reconstitutable preparations, nutritional pharmaceutical products and unit-dose sachets. FDA and EMA product documentation provides examples of approved medicinal products containing maltodextrin as an inactive ingredient.
Because maltodextrin is usually less sweet than glucose or sucrose, it can add solids and body without introducing excessive sweetness. It may also help distribute flavors and improve the mouthfeel of oral powders or liquids.
Dextrose equivalent, commonly abbreviated as DE, indicates the degree of starch hydrolysis.
A lower DE usually means that the maltodextrin contains a higher proportion of longer carbohydrate chains. A higher DE generally indicates more extensive hydrolysis and a greater proportion of shorter-chain carbohydrates.
DE can influence important formulation properties, including:
Sweetness
Solubility
Viscosity
Hygroscopicity
Reducing-sugar content
Browning tendency
Film formation
Powder-handling performance
The highest-DE material is not necessarily the best choice. Pharmaceutical formulators should select a maltodextrin grade according to the required viscosity, processing method, moisture sensitivity and final dosage form.
Food-grade and pharmaceutical-grade maltodextrin may be produced from similar starch sources, but they are selected and controlled for different applications.
Food-grade material is generally tested according to applicable food regulations or food chemical standards. Pharmaceutical-grade material must satisfy the required pharmacopoeial specification and pharmaceutical quality documentation.
The main differences may involve:
| Evaluation Area | Food Grade | Pharma Grade |
|---|---|---|
| Intended application | Food and beverage production | Pharmaceutical and healthcare formulations |
| Main standard | Food regulations or FCC requirements | BP, Ph. Eur., USP-NF or another pharmacopoeia |
| Documentation | Food-grade CoA and safety documents | Pharmaceutical CoA and regulatory support documents |
| Supplier qualification | Food-safety system focused | Pharmaceutical quality-system focused |
| Change control | May be application-dependent | Usually more important for validated formulations |
| Traceability | Food-batch traceability | Pharmaceutical batch and supply-chain traceability |
A food-grade product should not be substituted for pharmaceutical-grade maltodextrin without a complete technical and regulatory assessment.
Pharmaceutical buyers should evaluate more than product price. Important supplier-selection questions include:
Which pharmacopoeial editions does the product comply with?
Is the compliance claim supported by a batch-specific CoA?
What starch source is used?
What is the nominal DE range?
Can the supplier provide microbiological and impurity data?
Are allergen, GMO and BSE/TSE statements available?
What packaging sizes are offered?
Is the material produced under an appropriate quality-management system?
How are specification or manufacturing changes communicated?
Can pre-shipment samples be supplied for formulation testing?
Buyers should also provide their required standard, annual demand, destination country, preferred packaging and intended application when requesting a quotation.
Maltodextrin is usually packed in moisture-resistant bags with an inner polyethylene liner. Packaging size may vary by supplier and order quantity.
The product should generally be stored:
In a cool, dry and well-ventilated area
In tightly closed original packaging
Away from moisture and direct sunlight
Away from strong-smelling or incompatible materials
Under the conditions stated in the supplier’s specification
Because maltodextrin can absorb moisture from the environment, opened packaging should be resealed promptly. Any caking, discoloration, unusual odor or damaged packaging should be investigated before the material is released for production.
Maltodextrin BP EP USP pharma grade is a starch-derived pharmaceutical excipient used as a carrier, filler, binder, bulking agent, stabilizer and formulation aid. BP, EP and USP indicate the pharmacopoeial standards used to evaluate its identity, purity and quality.
For procurement, buyers should verify the exact compendial grade, current monograph edition, starch source, DE value, batch CoA and supporting regulatory documentation. The appropriate grade should then be confirmed through formulation trials and supplier qualification.
Shanghai Shicun Industrial Co., Ltd. supplies maltodextrin for international industrial and pharmaceutical purchasing requirements. Visit our Maltodextrin USP pharma grade page to review the product and submit your required specification, quantity, packaging and destination market.
Name: Mr.Zhonghua Zhao
Mobile:08618220867196
Tel:08615221391436
Whatsapp:8618220867196
Email:shsc20@xnshsc.com
Add:Room 205, 2 / F, Lane 16299, Puwei Road, Shanyang Town, Jinshan District, Shanghai